LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer Post author:Sam Post published:March 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like On a Roll: FDA Calls Sage's Depression Drug a Breakthrough February 6, 2018 FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb's Opdivo-Based Combo Trials September 6, 2017 FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017
FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017